Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term 80 and over Aged. Found 205 abstracts

no pagination
Kishan AU, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Sandler KA, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Stephenson AJ, Klein EA, Song DY, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco S, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer. Jama. 2018 Mar 06;319(9):896-905.
Shaikh T, Wang LS, Egleston B, Burki M, Hoffman JP, Cohen SJ, Meyer JE. Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic Cancer. Am J Clin Oncol. 2018 Jan;41(1):59-64.   PMCID: PMC4769977
Arthur DW, Winter KA, Kuerer HM, Haffty BG, Cuttino LW, Todor DA, Simone NL, Hayes SB, Woodward WA, McCormick B, Cohen RJ, Sahijdak WM, Canaday DJ, Brown DR, Currey AD, Fisher CM, Jagsi R, White J. NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence. Int J Radiat Oncol Biol Phys. 2017 Aug;98(5):1028-35.   PMCID: PMC5572128
Balar AV, Castellano D, O'Donnell PH, Grivas P, Vuky J, Powles T, Plimack ER, Hahn NM, de Wit R, Pang L, Savage MJ, Perini RF, Keefe SM, Bajorin D, Bellmunt J. First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study. Lancet Oncol. 2017 Sep 26;18(11):1483-92.
Bhimla A, Yap L, Lee M, Seals B, Aczon H, Ma GX. Addressing the Health Needs of High-Risk Filipino Americans in the Greater Philadelphia Region. J Community Health. 2017 Apr;42(2):269-77.   PMCID: PMC5337442
Choueiri TK, Plimack E, Arkenau HT, Jonasch E, Heng DY, Powles T, Frigault MM, Clark EA, Handzel AA, Gardner H, Morgan S, Albiges L, Pal SK. Biomarker-Based Phase II Trial of Savolitinib in Patients With Advanced Papillary Renal Cell Cancer. J Clin Oncol. 2017 Sep 10;35(26):2993-3001.
Epperla N, Maddocks KJ, Salhab M, Chavez JC, Reddy N, Karmali R, Umyarova E, Bachanova V, Costa C, Glenn M, Calzada O, Xavier AC, Zhou Z, Hossain NM, Hernandez-Ilizaliturri FJ, Al-Mansour Z, Barta SK, Chhabra S, Lansigan F, Mehta A, Jaglal MV, Evans A, Flowers CR, Cohen JB, Fenske TS, Hamadani M, Costa LJ. C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapy. Cancer. 2017 Nov 15;123(22):4411-8.
Kantarjian HM, Roboz GJ, Kropf PL, Yee KW, O'Connell CL, Tibes R, Walsh KJ, Podoltsev NA, Griffiths EA, Jabbour E, Garcia-Manero G, Rizzieri D, Stock W, Savona MR, Rosenblat TL, Berdeja JG, Ravandi F, Rock EP, Hao Y, Azab M, Issa JJ. Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial. Lancet Oncol. 2017 Aug 24;18(10):1317-26.
Kishan AU, Shaikh T, Wang PC, Reiter RE, Said J, Raghavan G, Nickols NG, Aronson WJ, Sadeghi A, Kamrava M, Demanes DJ, Steinberg ML, Horwitz EM, Kupelian PA, King CR. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. Eur Urol. 2017 May;71(5):766-73.
Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, Jervis S, van Leeuwen FE, Milne RL, Andrieu N, Goldgar DE, Terry MB, Rookus MA, Easton DF, Antoniou AC, Brca, Brca Cohort Consortium, McGuffog L, Evans DG, Barrowdale D, Frost D, Adlard J, Ong KR, Izatt L, Tischkowitz M, Eeles R, Davidson R, Hodgson S, Ellis S, Nogues C, Lasset C, Stoppa-Lyonnet D, Fricker JP, Faivre L, Berthet P, Hooning MJ, van der Kolk LE, Kets CM, Adank MA, John EM, Chung WK, Andrulis IL, Southey M, Daly MB, Buys SS, Osorio A, Engel C, Kast K, Schmutzler RK, Caldes T, Jakubowska A, Simard J, Friedlander ML, McLachlan SA, Machackova E, Foretova L, Tan YY, Singer CF, Olah E, Gerdes AM, Arver B, Olsson H. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. Jama. 2017 Jun 20;317(23):2402-16.
Lawton CA, Lin X, Hanks GE, Lepor H, Grignon DJ, Brereton HD, Bedi M, Rosenthal SA, Zeitzer KL, Venkatesan VM, Horwitz EM, Pisansky TM, Kim H, Parliament MB, Rabinovitch R, Roach M, Kwok Y, Dignam JJ, Sandler HM. Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202. Int J Radiat Oncol Biol Phys. 2017 Jun;98(2):296-303.   PMCID: PMC5603177
Lazar AJ, McLellan MD, Bailey MH, Miller CA, Appelbaum EL, Cordes MG, Fronick CC, Fulton LA, Fulton RS, Mardis ER, Schmidt HK, Wong W, Wilson RK, Yellapantula V, Radenbaugh AJ, Hoadley KA, Hayes DN, Parker JS, Wilkerson MD, Auma JT, Balu S, Bodenheimer T, Hoyle AP, Jefferys SR, Jones CD, Lehmann KV, Meng SW, Mieczkowski PA, Mose LE, Perou CM, Roach J, Senbabaoglu Y, Shi Y, Simons JV, Skelly T, Soloway MG, Tan DH, Veluvolu U, Davis IJ, Hepperla AJ, Brohl AS, Kasaian K, Mungall K, Sadeghi S, Barthel FP, Verhaak R, Hu X, Chibon F, Cherniack AD, Shih J, Beroukhim R, Meyerson M, Cibulskis C, Gabriel SB, Saksena G, Schumacher SE, Bailey MH, Gao QS, Wong WH, Wyczalkowski M, Bowlby R, Robertson AG, Ally A, Balasundaram M, Brooks D, Carlsen R, Chuah E, Dhalla N, Holt RA, Jones SJ, Lee D, Li I, Ma Y, Marra MA, Mayo M, Moore RA, Mungall AJ, Parker JS, Schein JE, Sipahimalani P, Tam A, Thiessen N, Wong T, Danilova L, Cope L, Baylin SB, Bootwalla MS, Lai PH, Laird PW, Maglinte DT, Van Den Berg DJ, Weisenberger DJ, Wrangle J, Drill E, Shen RL, Iype L, Reynolds SM, Shmulevich I, Yau C, Armenia J, Liu EM, Benz C, Pastore A, Sanchez-Vega F, Schultz N, Akbani R, Hegde AM, Liu WB, Lu Y, Mills GB, Weinstein JN, Roszik J, Anur P, Spellman P, Abeshouse A, Chen HW, Gao J, Heins Z, Kundra R, Larsson E, Ochoa A, Sanchez-Vega F, Sander C, Schultz N, Socci N, Zhang HX, Noble MS, Heiman DI, Kim J, Chin L, Getz G, Cho J, Defreitas T, Frazer S, Gehlenborg N, Lawrence MS, Lin P, Meier S, Voet D, Zhang HL, Byers L, Diao LX, Gay CM, Wang J, Newton Y, Cooper LA, Gutman DA, Lazar AJ, Lee S, Nalisnik M, Bowen J, Gastier-Foster JM, Gerken M, Helsel C, Hobensack S, Leraas KM, Lichtenberg TM, Ramirez NC, Wise L, Zmuda E, Anderson ML, Castro P, Ittmann M, Gordienko E, Paklina O, Setdikova G, Raut CP, Karlan BY, Lester J, Belyaev D, Fulidou V, Potapova O, Voronina O, Demetri GD, Ramalingam SS, Behera M, Delman K, Owonikoko TK, Sica GL, Boyd J, Magliocco A, Salner A, Bennett J, Iacocca M, Swanson P, Dottino P, Kalir T, Pereira E, Akeredolu T, Crain D, Curley E, Gardner J, Mallery D, Morris S, Paulauskis J, Penny R, Shelton C, Shelton T, Thompson E, Hoon DB, Parfitt J, Birrer M, Karseladze A, Mariamidze A, Dao F, Levine DA, Olvera N, Maki RG, Bartlett J, Eschbacher J, Dubina M, Mozgovoy E, Fedosenko K, Manikhas G, Sekhon H, Ramirez N, Lazar AJ, Ingram DR, Torres KE, DiSaia P, Godwin AK, Godwin EM, Kuo H, Madan R, Reilly C, Adebamowo C, Adebamowo SN, Bocklage T, Higgins K, Martinez C, Auman JT, Boice L, Grilley-Olson JE, Huang M, Perou AH, Thorne LB, Rathmell WK, Gutmann DH, Singer S, Chudamani S, Liu J, Lolla L, Naresh R, Pihl T, Sun Q, Wan YH, Wu Y, Felau I, Zenklusen JC, Demchok JA, Ferguson ML, Hutter CM, Sofia HJ, Tarnuzzer R, Wang ZN, Yang LM, Zhang JS, Demicco EG, Doyle LA, Hornick JL, Lazar AJ, Rubin BP, de Rijn MV, Demetri GD, Baker L, Grilley-Olson JE, Iype L, Lazar AJ, Lichtenberg TM, Raut CP, Riedel RF, Demicco EG, Ding L, Ladanyi M, Lazar AJ, Novak JE, Sanchez-Vega F, Singer S, Van Tine BA, Byers L, Cope L, Cherniack AD, Cooper LA, Davis IJ, Davis LE, Demetri GD, Doyle LA, Drill E, Godwin AK, Grilley-Olsen JE, Gutmann DH, Hayes DN, Hepperla AJ, Hoadley KA, Hoon DB, Hornick JL, Iype L, Kim J, Maki RG, Pollock RE, Raut CP, Riedel RF, Robertson AG, Rubin BP, Shih J, Weinstein JN, Wong WH, Akbani R, Anderson ML, Anur P, Bailey MH, Benz C, Bowen J, Bowlby R, Brohl AS, Cherniack AD, Cooper LA, Cope L, Danilova L, Davis LE, Demetri GD, Gay CM, Godwin AK, Grilley-Olson JE, Gutman DA, Hegde AM, Jones KB, Kasaian K, Ladanyi M, Lazar AJ, Lee S, Leraas KM, Lichtenberg TM, Martignetti JA, McLellan MD, Miller CA, Mungall K, Nalisnik M, Noble MS, Raut CP, Riedel RF, Robertson AG, Roszik J, Sadeghi S, Sanchez-Vega F, Shen RL, Shih J, Tong P, Torres KE, Yau C, Zenklusen JC, Canc Genome Atlas Res N. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov;171(4):950-965 e28.   PMCID: PMC5693358
Maegawa S, Lu Y, Tahara T, Lee JT, Madzo J, Liang S, Jelinek J, Colman RJ, Issa JJ. Caloric restriction delays age-related methylation drift. Nat Commun. 2017 Sep 14;8(1):539.   PMCID: PMC5599616
Mirhadi AJ, Zhang Q, Hanks GE, Lepor H, Grignon DJ, Peters CA, Rosenthal SA, Zeitzer K, Radwan JS, Lawton C, Parliament MB, Reznik RS, Sandler HM. Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202. Int J Radiat Oncol Biol Phys. 2017 Mar;97(3):511-5.   PMCID: PMC5485922
Moore KN, Martin LP, O'Malley DM, Matulonis UA, Konner JA, Perez RP, Bauer TM, Ruiz-Soto R, Birrer MJ. Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study. J Clin Oncol. 2017 Apr;35(10):1112-8.   PMCID: PMC5559878
Pickhardt PJ, Edwards K, Bruining DH, Gollub M, Kupfer S, Lubner SJ, Kim DH, Ross E, Keenan E, Weinberg DS. Prospective Trial Evaluating the Surgical Anastomosis at One-Year Colorectal Cancer Surveillance: CT Colonography Versus Optical Colonoscopy and Implications for Patient Care. Diseases of the colon and rectum. 2017 Nov;60(11):1162-7.   PMCID: PMC5635837
Waingankar N, Mallin K, Smaldone M, Egleston BL, Higgins A, Winchester DP, Uzzo RG, Kutikov A. Assessing the relative influence of hospital and surgeon volume on short-term mortality after radical cystectomy. BJU international. 2017 Aug;120(2):239-45.
Wang LS, Handorf EA, Wu H, Liu JC, Perlis CS, Galloway TJ. Surgery and Adjuvant Radiation for High-risk Skin Adnexal Carcinoma of the Head and Neck. Am J Clin Oncol. 2017 Aug;40(4):429-32.   PMCID: PMC4504824
Xu MJ, Chu C, Rubin S, Lin LL. Survival Outcomes Improved in Contemporary Cohort of Patients With Pelvic or Abdominal Recurrence After Treatment for Stage I/II Endometrial Carcinoma. Am J Clin Oncol. 2017 Dec;40(6):598-604.   PMCID: PMC4733581
Chang EI, Jenkins MP, Patel SA, Topham NS. Long-Term Operative Outcomes of Preoperative Computed Tomography-Guided Virtual Surgical Planning for Osteocutaneous Free Flap Mandible Reconstruction. Plast Reconstr Surg. 2016 Feb;137(2):619-23.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term 80 and over Aged

Middle Aged 80 and over Aged Aged Adult Female Male mortality pathology therapeutic use Disease-Free Survival Retrospective Studies methods therapy adverse effects Treatment Outcome Young Adult drug therapy Neoplasm Staging Kaplan-Meier Estimate Prospective Studies genetics Follow-Up Studies Survival Analysis surgery Combined Modality Therapy statistics & numerical data administration & dosage Prognosis Adolescent Local Neoplasm Recurrence Androgen Antagonists Time Factors Drug Administration Schedule Prostatic Neoplasms Neoplasm Grading Risk Assessment analogs & derivatives Drug Dose-Response Relationship Neoplasm Invasiveness Brachytherapy Adenocarcinoma Radiotherapy Adjuvant Radiotherapy radiotherapy diagnostic imaging antagonists & inhibitors Salvage Therapy diagnosis Proportional Hazards Models epidemiology Conformal Radiotherapy Propensity Score Monoclonal Antibodies-Humanized Incidence Prostatectomy Radiation Injuries Maximum Tolerated Dose Intravenous Infusions Neoplasm Metastasis Ovarian Neoplasms Breast Neoplasms Age Factors Cohort Studies Neoplasm Drug Resistance Mutation Chemoradiotherapy Prostate-Specific Antigen Patient Safety Survival Rate Antineoplastic Combined Chemotherapy Protocols blood Clear Cell Adenocarcinoma Organs at Risk basic helix-loop-helix (MYC) Cystectomy DNA Methylation Health Behavior Fatigue Endometrioid Carcinoma Clinical Competence immune infiltration Hypotension Exercise Disease Progression Community health Multivariate Analysis Dietary behaviors Cisplatin Remission Induction Flutamide Transitional Cell Carcinoma High-Volume Hospitals Preschool Child Fallopian Tube Neoplasms non-Hodgkin lymphoma Infant Dose Fractionation Surgical Anastomosis Aging genomics Pancreatic Neoplasms Hematopoietic Stem Cell Transplantation Colon Rectum Tumor Biomarkers undifferentiated pleomorphic sarcoma Diet Preoperative Care Registries Sarcoma Gleason 9 Intraductal Carcinoma-Noninfiltrating DNA methylation Fibrosis Paclitaxel Intensity-Modulated Radiotherapy etiology Radiation Oncology Adnexal and Skin Appendage Neoplasms leiomyosarcoma myxofibrosarcoma Aftercare Myeloid Leukemia-Acute myc Genes physiopathology Oral Administration Age Distribution Patient Care Planning Urinary Bladder Neoplasms Hysterectomy Health Services Needs and Demand Reoperation Kidney Neoplasms hematopoietic cell transplantation (HCT) regionalization Predictive Value of Tests Internationality molecular subtype Retreatment radiation effects outcomes BRCA2 Genes diffuse large B-cell lymphoma (DLBCL) Platinum Compounds Longevity BRCA1 Genes Abdominal Neoplasms Carboplatin chemically induced Treatment Failure
Last updated on Tuesday, April 03, 2018